Silkworm as a Host of Baculovirus Expression
Authors: Usami, Akihiro; Suzuki, Takeo; Nagaya, Hidekazu; Kaki, Hiroki; Ishiyama, Seiji
Source: Current Pharmaceutical Biotechnology, Volume 11, Number 3, April 2010 , pp. 246-250(5)
Publisher: Bentham Science Publishers
Abstract:While the Baculovirus Expression Vector System (BEVS) mainly uses insect cell lines, such as Sf9 cells, the robust high expression system using silkworm has also been developed. We have further improved technologies for enhancement of virus recombination, reduction of proteolytic degradation and aggregation, and more reliable promoters. These developments made it possible to achieve high and soluble expression of recombinant proteins. We review here such technology developments, advantage of using silkworm and some example applications. There are areas where this technology can be further improved as implicated in the end.
Document Type: Research Article
Publication date: April 1, 2010
- Current Pharmaceutical Biotechnology aims to cover all the latest and outstanding developments in Pharmaceutical Biotechnology. Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics in both pre-clinical and clinical areas of Pharmaceutical Biotechnology. Current Pharmaceutical Biotechnology is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments.